Journal of Immunology Research

Journal of Immunology Research / 2020 / Article

Corrigendum | Open Access

Volume 2020 |Article ID 1786505 | https://doi.org/10.1155/2020/1786505

JunLi Xue, XiaoXiao Ge, Wei Zhao, Liqiong Xue, Congqi Dai, Fengjuan Lin, Wei Peng, "Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”", Journal of Immunology Research, vol. 2020, Article ID 1786505, 1 page, 2020. https://doi.org/10.1155/2020/1786505

Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”

Received12 Sep 2020
Accepted12 Sep 2020
Published30 Sep 2020

In the article titled “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling” [1], the Acknowledgments section should read as follows:

Acknowledgments

This work was supported by the Excellent Young Doctor Training Program of Shanghai Pudong New Area (PWRq2017-26), the Fundamental Research Funds for the Central Universities (22120180331), the Outstanding Clinical Discipline Project of Shanghai Pudong (PWYgy2018-02), and the National Natural Science Foundation of China (Grant No. 81702360).

References

  1. J. L. Xue, X. X. Ge, W. Zhao et al., “PIPKIγ Regulates CCL2 expression in colorectal cancer by activating AKT-STAT3 signaling,” Journal of Immunology Research, vol. 2019, Article ID 3690561, 12 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2020 JunLi Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views51
Downloads23
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.